NCT06802731 LivQ-box® Parameters in the Diagnosis of Liver Inflammation
| NCT ID | NCT06802731 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wuxi Hisky Medical Technology Co Ltd |
| Condition | Liver Inflammation |
| Study Type | OBSERVATIONAL |
| Enrollment | 365 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2025-03-31 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
To evaluate the correlation between LivQ-box® parameters carried by iLivTouch and liver inflammation in patients with NAFLD, as well as the diagnostic value of liver inflammation of different severity levels.
Eligibility Criteria
Inclusion Criteria: * Patients diagnosed with NAFLD according to The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases; * Age over 18 years old, gender not limited; * Not combined with liver diseases (such as viral hepatitis, drug-induced liver injury, autoimmune liver disease); * Perform iLivTouch examination within ± 14 days of liver pathology examination; * No history of excessive alcohol consumption (converted to ethanol:\<140g/week for males,\<70g/week for females);